✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Mangalam Drugs And Organics Ltd.

MANGALAM

Market Cap
₹115 Cr.
P/E
11.24

Mangalam Drugs And Organics Ltd.

  • Mangalam Drugs&Org.
  • Smruthi Organics
  • Tyche Inds
FAQs on Mangalam Drugs And Organics Ltd. Shareprice

Mangalam Drugs&Org. has given lower returns compared to its competitors.
Mangalam Drugs&Org. has grown at ~-10.69% over the last 7yrs while peers have grown at a median rate of 4.57%

Mangalam Drugs&Org. is not expensive.
Latest PE of Mangalam Drugs&Org. is 11.24, while 3 year average PE is 15.86.
Also latest EV/EBITDA of Mangalam Drugs&Org. is 4.92 while 3yr average is 11.66.

View FAQ's On Business
Growth Table
  • Mangalam Drugs And Organics Ltd.
  • Smruthi Organics
  • Tyche Inds
Balance Sheet
  • Mangalam Drugs And Organics Ltd.
  • Smruthi Organics
  • Tyche Inds
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Mangalam Drugs And Organics Ltd.
  • Smruthi Organics
  • Tyche Inds
Cash Flow
  • Mangalam Drugs And Organics Ltd.
  • Smruthi Organics
  • Tyche Inds
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Mangalam Drugs And Organics Ltd.
  • Smruthi Organics
  • Tyche Inds
Quarterly Results
  • Mangalam Drugs And Organics Ltd.
  • Smruthi Organics
  • Tyche Inds
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Mangalam Drugs And Organics Ltd. Financials

Balance sheet of Mangalam Drugs&Org. is moderately strong, But short term working capital might become an issue for this company.

The net debt of Mangalam Drugs&Org. is decreasing.
Latest net debt of Mangalam Drugs&Org. is ₹68.64 Crs as of Sep-24.
This is less than Mar-24 when it was ₹92.79 Crs.

The profit is oscillating.
The profit of Mangalam Drugs&Org. is ₹10.19 Crs for TTM, -₹9.07 Crs for Mar 2024 and ₹1.27 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Mangalam Drugs&Org. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech